Clinical Trial Update: H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology [Phase 1]

View source ↗

Summary

Phase 1 study in healthy adults comparing an H5N8 influenza vaccine formulated with or without AS03 or MF59 adjuvants; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• AS03 adjuvant (AS03)
• H5N8 influenza vaccine (influenza vaccine H5N8)
• MF59 adjuvant (MF59)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Avian Influenza | Phase 1 | Status: COMPLETED